eDiagnosis(002932)2024-10-30 08:53Financial Performance - The company's revenue for Q3 2024 was ¥71,347,454.86, a decrease of 19.26% compared to the same period last year[3]. - Net profit attributable to shareholders was ¥15,775,795.11, down 51.80% year-on-year[3]. - The net profit after deducting non-recurring gains and losses was -¥10,253,861.09, reflecting a decline of 197.08%[3]. - Total operating revenue for Q3 2024 was CNY 225,617,843.38, a decrease of 64.0% compared to CNY 625,927,735.10 in the same period last year[14]. - The company's operating profit for Q3 2024 was 82,281,071.77 CNY, a decrease from 219,347,804.88 CNY in the same period last year[15]. - Net profit for Q3 2024 was 62,363,772.16 CNY, down from 182,663,407.68 CNY year-over-year[15]. - The total comprehensive income attributable to the parent company's owners for Q3 2024 was 62,363,772.16 CNY, compared to 182,663,407.68 CNY in the same period last year[16]. Assets and Liabilities - Total assets at the end of the reporting period were ¥6,829,941,182.42, a decrease of 7.54% from the end of the previous year[3]. - The company's total liabilities decreased by 42.97% due to payments made to suppliers[6]. - Total liabilities decreased to CNY 719,619,025.51 from CNY 1,094,498,430.83, a reduction of 34.3%[14]. - Total assets decreased to CNY 6,829,941,182.42 from CNY 7,386,599,894.20, a decline of 7.5%[14]. Cash Flow - The company's cash flow from operating activities was -¥123,266,443.84, representing a decline of 176.95% year-on-year[3]. - The net cash flow from operating activities was -123,266,443.84 CNY, compared to 160,198,960.51 CNY in the previous year, indicating a significant decline[18]. - Cash outflow for operating activities was 812,864,780.68 CNY, compared to 1,308,326,996.19 CNY in the previous year[18]. - The net cash flow from investment activities was -144,743,616.48 CNY, compared to 262,657,014.01 CNY in the same period last year[18]. - The net cash flow from financing activities was -250,643,991.12 CNY, compared to -613,141,358.87 CNY in the previous year, showing an improvement[18]. - The total cash and cash equivalents at the end of the period were 394,336,276.36 CNY, down from 2,366,471,800.49 CNY year-over-year[19]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 31,812[8]. - The largest shareholder, Chen Lili, holds 27.06% of the shares, while the second-largest shareholder, Wang Ying, holds 15.45%[8]. - The company did not have any preferred shareholders or related changes in the top ten shareholders due to securities lending[9]. Dividends and Share Repurchase - As of September 30, 2024, the company repurchased 9,547,867 shares, accounting for 4.11% of the total share capital, with a total transaction amount of RMB 182,108,714.69[9]. - The company's cash dividend distribution plan for the first half of 2024 was approved, with a cash dividend of RMB 0.30 per 10 shares (including tax) to be distributed[10]. Operational Metrics - Basic earnings per share were ¥0.07, down 50.00% compared to the same period last year[3]. - The weighted average return on equity was 0.27%, a decrease of 0.27% from the previous year[3]. - Research and development expenses amounted to 86,244,236.06 CNY, compared to 106,632,983.58 CNY in the previous year, indicating a reduction of approximately 19%[15]. - The basic earnings per share for Q3 2024 was 0.35 CNY, down from 0.63 CNY in the previous year[16]. Other Notable Points - The company received government subsidies amounting to ¥233,465.96 during the reporting period[4]. - The company reported a significant increase in construction in progress, which rose by 141.44% to ¥447,115,145.95, attributed to the industrial park project[6]. - The company did not report any new product or technology developments in this quarter[9]. - There were no significant mergers or market expansion strategies mentioned in the report[9].